Premium
NICE's future without a veto on the use of expensive drugs
Author(s) -
Chaplin Steve
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.706
Subject(s) - nice , veto , medicine , interface (matter) , law and economics , risk analysis (engineering) , intensive care medicine , law , engineering , computer science , economics , politics , political science , programming language , pulmonary surfactant , gibbs isotherm , chemical engineering
Steve Chaplin describes NICE's future role after it loses the power to decide whether the use of a new drug will be cost effective. Copyright © 2011 Wiley Interface Ltd